Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8342)
All Articles published online
|
Publishing Process of This Article
|
Sep 27, 2020 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Singh G, Yoshida EM, Rathi S, Marquez V, Kim P, Erb SR, Salh BS. Biomarkers for hepatocellular cancer. World J Hepatol 2020; 12(9): 558-573 [PMID: 33033565 DOI: 10.4254/wjh.v12.i9.558] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i9/558.htm |
| Number | Citing Articles |
| 1 |
Edward Kurnia Setiawan Limijadi, Ardiyana Ar, Nurul Azizah Dian Rahmawati, I Nyoman Sebastian Sudiasa, Kevin Christian Tjandra. The role of salivary orosomucoid 1 as an early diagnostic and prognostic biomarker of hepatocellular carcinoma related to Hepatitis B: A systematic review. F1000Research 2023; 12: 401 doi: 10.12688/f1000research.132034.1
|
| 2 |
Xiyan Xiang, Krishanu Bhowmick, Kirti Shetty, Kazufumi Ohshiro, Xiaochun Yang, Linda L. Wong, Herbert Yu, Patricia S. Latham, Sanjaya K. Satapathy, Christina Brennan, Richard J. Dima, Nyasha Chambwe, Gulru Sharifova, Fellanza Cacaj, Sahara John, James M. Crawford, Hai Huang, Srinivasan Dasarathy, Adrian R. Krainer, Aiwu R. He, Richard L. Amdur, Lopa Mishra. Mechanistically based blood proteomic markers in the TGF-β pathway stratify risk of hepatocellular cancer in patients with cirrhosis. Genes & Cancer 2024; 15: 1 doi: 10.18632/genesandcancer.234
|
| 3 |
Sakshi Tiwari, Bilal Siddiqui, Shilpy Singh, Afsana Praveen. Tumor Microenvironment: a Therapeutic Aid in Cancer. Indian Journal of Surgery 2024; 86(1): 57 doi: 10.1007/s12262-023-03828-7
|
| 4 |
Natalia Salinas Parra, Heather M. Ross, Adnan Khan, Marisa Wu, Risa Goldberg, Lokesh Shah, Sarah Mukhtar, Jacob Beiriger, Alexis Gerber, Dina Halegoua-DeMarzio. Advancements in the Diagnosis of Hepatocellular Carcinoma. International Journal of Translational Medicine 2023; 3(1): 51 doi: 10.3390/ijtm3010005
|
| 5 |
A. S. Shkaraburov, D. N. Rudenko, E. F. Vaiman, O. M. Soboleva, Yu. V. Zakharova. Asymptomatic Hepatocellular Carcinoma (Clinical Case). Creative surgery and oncology 2022; 12(3): 256 doi: 10.24060/2076-3093-2022-12-3-256-260
|
| 6 |
Matteo Canale, Francesco Giuseppe Foschi, Pietro Andreone, Giorgio Ercolani, Giorgia Marisi, Fabio Conti, Ranka Vukotic, Valeria Guarneri, Valentina Burgio, Francesca Ratti, Luca Aldrighetti, Francesco De Cobelli, Stefano Cascinu, Paola Ulivi, Andrea Casadei-Gardini. Role of circulating microRNAs to predict hepatocellular carcinoma recurrence in patients treated with radiofrequency ablation or surgery. HPB 2022; 24(2): 244 doi: 10.1016/j.hpb.2021.06.421
|
| 7 |
Xiaoyue Ren, Alex Li, Edward Ying, Jhin Fang, Mingzhu Li, Jiao Yu. Upregulation of ubiquitin-conjugating enzyme E2T (UBE2T) predicts poor prognosis and promotes hepatocellular carcinoma progression. Bioengineered 2021; 12(1): 1530 doi: 10.1080/21655979.2021.1918507
|
| 8 |
Yunxi Liu, Yue Chen, Weidong Fei, Caihong Zheng, Yongquan Zheng, Miao Tang, Ying Qian, Xiao Zhang, Mengdan Zhao, Meng Zhang, Fengmei Wang. Silica-Based Nanoframeworks Involved Hepatocellular Carcinoma Theranostic. Frontiers in Bioengineering and Biotechnology 2021; 9 doi: 10.3389/fbioe.2021.733792
|
| 9 |
Wojciech Książek, Filip Turza, Paweł Pławiak. NCA‐GA‐SVM: A new two‐level feature selection method based on neighborhood component analysis and genetic algorithm in hepatocellular carcinoma fatality prognosis. International Journal for Numerical Methods in Biomedical Engineering 2022; 38(6) doi: 10.1002/cnm.3599
|
| 10 |
Cyriac A Philips, Sasidharan Rajesh, Dinu C Nair, Rizwan Ahamed, Jinsha K Abduljaleel, Philip Augustine. Hepatocellular Carcinoma in 2021: An Exhaustive Update. Cureus 2021; doi: 10.7759/cureus.19274
|
| 11 |
Dongxu Zhao, Jian Cao, Lei Zhang, Shaohua Zhang, Song Wu. Targeted Molecular Imaging Probes Based on Magnetic Resonance Imaging for Hepatocellular Carcinoma Diagnosis and Treatment. Biosensors 2022; 12(5): 342 doi: 10.3390/bios12050342
|
| 12 |
Soo Young Jun, Hyang Ran Yoon, Ji-Yong Yoon, Su-Jin Jeon, Jeong-Ju Lee, Debasish Halder, Jin-Man Kim, Nam-Soon Kim. The Human TOR Signaling Regulator Is the Key Indicator of Liver Cancer Patients’ Overall Survival: TIPRL/LC3/CD133/CD44 as Potential Biomarkers for Early Liver Cancers. Cancers 2021; 13(12): 2925 doi: 10.3390/cancers13122925
|
| 13 |
Ishfaq Hassan Mir, K. C. Jyothi, Chinnasamy Thirunavukkarasu. The prominence of potential biomarkers in the diagnosis and management of hepatocellular carcinoma: Current scenario and future anticipation. Journal of Cellular Biochemistry 2022; 123(10): 1607 doi: 10.1002/jcb.30190
|
| 14 |
Luis M. Ruiz-Manriquez, Oscar Carrasco-Morales, E. Adrian Sanchez Z, Sofía Madeline Osorio-Perez, Carolina Estrada-Meza, Surajit Pathak, Antara Banerjee, Anindya Bandyopadhyay, Asim K. Duttaroy, Sujay Paul. MicroRNA-mediated regulation of key signaling pathways in hepatocellular carcinoma: A mechanistic insight. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.910733
|
| 15 |
Pooja Basthi Mohan, Rajiv Lochan, Shiran Shetty. Biomarker in Hepatocellular Carcinoma. Indian Journal of Surgical Oncology 2024; doi: 10.1007/s13193-023-01858-x
|
| 16 |
Jiarong Li, Nianfeng Li, Muhammad Salman Azhar, Ling Liu, Liheng Wang, Qi Zhang, Langqing Sheng, Jianhua Wang, Sijia Feng, Qixuan Qiu, Yao Xiao. Analysis of mutations in DNA damage repair pathway gene in Chinese patients with hepatocellular carcinoma. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-16604-6
|
| 17 |
S Pilar Zamora-León. Hepatocellular carcinoma biomarkers, an imminent need. World Journal of Gastrointestinal Oncology 2021; 13(11): 1847-1849 doi: 10.4251/wjgo.v13.i11.1847
|
| 18 |
Jingjing Li, Sang Hyuk Lee, Dong Kyu Yoo, Ho Chul Woo, Sung Hwa Jhung, Milica Jović, Hubert Girault, Hye Jin Lee. A spatially multiplexed voltammetric magneto-sandwich assay involving Fe3O4/Fe-based metal-organic framework for dual liver cancer biomarkers. Sensors and Actuators B: Chemical 2023; 380: 133313 doi: 10.1016/j.snb.2023.133313
|
| 19 |
Jessica Evangelista, Elisa Zaninotto, Annalisa Gaglio, Michele Ghidini, Lucrezia Raimondi. MicroRNAs as Diagnostic Tools in Hepatocellular Carcinoma. Gastrointestinal Disorders 2021; 3(4): 237 doi: 10.3390/gidisord3040022
|
| 20 |
Rosa M. Pascale, Diego F. Calvisi, Francesco Feo, Maria M. Simile. Genetic Predisposition to Hepatocellular Carcinoma. Metabolites 2022; 13(1): 35 doi: 10.3390/metabo13010035
|
| 21 |
Teerha Piratvisuth, Jinlin Hou, Tawesak Tanwandee, Thomas Berg, Arndt Vogel, Jörg Trojan, Enrico N. De Toni, Masatoshi Kudo, Anja Eiblmaier, Hanns-Georg Klein, Johannes Kolja Hegel, Kairat Madin, Konstantin Kroeniger, Ashish Sharma, Henry L.Y. Chan. Development and clinical validation of a novel algorithmic score (GAAD) for detecting HCC in prospective cohort studies. Hepatology Communications 2023; 7(11) doi: 10.1097/HC9.0000000000000317
|
| 22 |
Chenjun Huang, Xiao Xiao, Lin Zhou, Fuxiang Chen, Jianyi Wang, Xiaobo Hu, Chunfang Gao. Chinese expert consensus statement on the clinical application of AFP/AFP‐L3%/DCP using GALAD and GALAD‐like algorithm in HCC. Journal of Clinical Laboratory Analysis 2023; 37(23-24) doi: 10.1002/jcla.24990
|
| 23 |
Francisco Villalba-López, Luis Francisco Sáenz-Mateos, Maria Isabel Sánchez-Lorencio, Virginia De La Orden-García, Felipe Alconchel-Gago, Pedro Antonio Cascales-Campos, Carmen García-Bernardo, José Antonio Noguera-Velasco, Alberto Baroja-Mazo, Pablo Ramírez-Romero. Usefulness of PIVKA-II for monitoring after liver transplantation in patients with hepatocellular carcinoma. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-32879-9
|
| 24 |
Laura Marinela Ailioaie, Constantin Ailioaie, Gerhard Litscher. Synergistic Nanomedicine: Photodynamic, Photothermal and Photoimmune Therapy in Hepatocellular Carcinoma: Fulfilling the Myth of Prometheus?. International Journal of Molecular Sciences 2023; 24(9): 8308 doi: 10.3390/ijms24098308
|
| 25 |
Jose Israel Suarez-Rodriguez, Chin-Chi Liu, Shannon Dehghanpir, Andrea N. Johnston. Lymphopenia predicts reduced survival in canine hepatocellular carcinoma. Journal of Veterinary Science 2023; 24(3) doi: 10.4142/jvs.22266
|
| 26 |
Onyinye Ugonabo, Utibe-Abasi Sunday Udoh, Pradeep Kumar Rajan, Heather Reeves, Christina Arcand, Yuto Nakafuku, Tejas Joshi, Rob Finley, Sandrine V. Pierre, Juan Ramon Sanabria. The Current Status of the Liver Liquid Biopsy in MASH Related HCC: Overview and Future Directions. Biomolecules 2023; 13(9): 1369 doi: 10.3390/biom13091369
|
| 27 |
Gauhar Rehman. Cancer Biomarkers in Diagnosis and Therapeutics. 2022; : 65 doi: 10.1007/978-981-16-5759-7_3
|
| 28 |
Edward Kurnia Setiawan Limijadi, Ardiyana Ar, Nurul Azizah Dian Rahmawati, I Nyoman Sebastian Sudiasa, Kevin Christian Tjandra. The role of salivary orosomucoid 1 as an early diagnostic and prognostic biomarker of hepatocellular carcinoma related to Hepatitis B: A systematic review. F1000Research 2023; 12: 401 doi: 10.12688/f1000research.132034.2
|